Assessment of the methods used to detect HER2-positive advanced extramammary Paget’s disease
Sign Up to like & getrecommendations! Published in 2018 at "Medical Oncology"
DOI: 10.1007/s12032-018-1154-z
Abstract: The human epidermal growth factor receptor 2 (HER2) is recognized as an oncogene as well as a therapeutic target in various cancers. Certain patients with advanced extramammary Paget’s disease (EMPD) have also been reported to… read more here.
Keywords: her2 positive; empd; extramammary paget; advanced extramammary ... See more keywords